COAGULATION & THROMBOSIS RELATED RESEARCH 1. Apixaban is Associated with the Lowest Risk of GI Bleed Among the Various DOACs BACKGROUND: Current guidelines recommend using …
Read moreCategory: Targeted Research
Product Q & A From Our Major Sponsor
Q: Does lumbrokinase work like other systemic enzymes (I am thinking here of products like Wobenzym N.) and digest or cleave proteins that are foreign …
Read moreCould Treatments that Decrease Blood Viscosity Reduce Mortality Rate in Hospitalized COVID-19 Patients?
BACKGROUND: Coronavirus disease-2019 (COVID-19) is characterized by a dysfunctional immune response and abnormal blood rheology that contribute to endothelial dysfunction and thrombotic complications. Whole blood …
Read moreLp(a) and Coronary Artery Calcium Score are Independently Associated with Atherosclerotic Cardiovascular Disease
BACKGROUND: Elevated lipoprotein(a) [Lp(a)] and coronary artery calcium (CAC) score are individually associated with increased atherosclerotic cardiovascular disease (ASCVD) risk but have not been studied in …
Read morePost-PCI Ticagrelor Monotherapy May Lower Bleeding Risk Without Compromising Ischemia Prevention in Patients with Prior MI
OBJECTIVES: The aim of this study was to evaluate if patients with prior myocardial infarction (MI) could benefit from ticagrelor monotherapy in terms of bleeding reduction …
Read moreThe Risk of Arterial and Venous Thromboembolism Remains Elevated up to 49 Weeks After COVID-19 Diagnosis
BACKGROUND: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular diseases are unclear. …
Read moreOral Anticoagulants May Help In Resolving Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement
ABSTRACT: This meta-analysis and systematic review was performed to evaluate the clinical relevance of subclinical leaflet thrombosis (SLT) following transcatheter aortic valve replacement. PubMed, Web …
Read moreDe-Escalating From Dual Antiplatelet Therapy May Reduce Bleeding Risk Without Sacrificing The Protective Effects For Acute Coronary Syndrome Patients
BACKGROUND: Balancing the effects of dual antiplatelet therapy (DAPT) in the era of potent P2Y12 inhibitors has become a cornerstone of acute coronary syndrome (ACS) management. Recent …
Read moreProduct Q & A From Our Major Sponsor
Q: My wife has been using Boluoke® for a number of years now. Even though I am at 69 generally in good health, I was …
Read moreProduct Q & A From Our Major Sponsor
Q: I am taking Boluoke® every day, because I have three small Lacunar cerebral infarctions. Will this help? I am also taking several vitamins at …
Read more